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High-resolution proton NMR spectra of normal human brain in vivo have been ob- 
tained from selected 27- and 64-ml volumes-of-interest (VOI) localized in the insular 
area, the occipital area, the thalamus, and the cerebellum of normal volunteers. Localiza- 
tion was achieved by stimulated echo (STEAM) sequences using a conventional 1.5-T 
whole-body MRI system (Siemens Magnetom). The proton NMR spectra show reso- 
nances from lipids, lactate, acetate, N-acetylaspartate (NAA), y-aminobutyrate, gluta- 
mine, glutamate, aspartate, creatine and phosphocreatine, choke-containing com- 
pounds, taurine, and inositols. While TI  relaxation times of most of these metabolites 
were about 1100-1700 ms without significant regional differences, their T2 relaxation 
times varied between 100 and 500 ms. The longest T2 values of about (500 f 50) ms were 
observed for the methyl protons of NAA in the white matter of the occipital lobe com- 
pared to (320 % 30) ms in the other parts of the brain. No significant regional T, differ- 
ences were found for choline and creatine methyl resonances. The relative concentrations 
of NAA in gray and white matter were found to be 35% higher than those in the thalamus 
and cerebellum. Assuming a concentration of 10 &for total creatine the resulting NAA 
concentrations of 13- I8 mMare by a factor of 2-3 higher than previously reported using 
analytical techniques. Cerebral lactate reached a maximum concentration of about 1 .O 
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INTRODUCTION 
Complementary to anatomical and functional studies by magnetic resonance im- 
aging (MRI), localized in vivo NMR spectroscopy opens the way to a biochemical 
characterization of tissues and their diseased states. Noninvasive insights may be 
gained into the metabolism of a variety of compounds within the whole living organ- 
ism. Moreover, many biochemical and physiological questions may now be investi- 
gated in human subjects rather than in animals, avoiding the need of anesthesia and 
associated physiological complications as well as the uncertainties in establishing a 
correlation between animal studies and human applications. 
In particular, proton NMR spectroscopy is expected to broaden our understanding 
of metabolic processes in viva The abundant representation of protons in molecules 
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FIG. I .  Sixty-four-megahertz (1.5-T) FLASH MR images (40", TR = 100 ms, TE = 1 1 ms) and localized 
proton NMR spectra of a normal volunteer from a 4 X 4 X 4 cm3 VOI in the occipital area of the brain 
selected for in vivo spectroscopy of predominantly white matter. (a) Axial image, (b) coronal image, and 
(c) series ofspectra at echo times TE = 50, 135, and 270 ms, respectively, demonstrating the T2 dependence 
of the individual metabolites (64 ml, TR = 1500 ms, 512 scans). Assignments of metabolites include 
lactate (Lac), N-acetylaspartate (NAA), aspartate (Asp), creatine (Cr) and phosphocreatine (PCr), choline- 
containing compounds (Cho), taurine (Tau), and inositols (Ins). 
of biological interest gives access to the pool of free amino acids, neurotransmitters, 
fatty acids, and carbohydrates as well as to compounds related to the energy metabo- 
lism (see, e.g., Ref. (I)). In addition, the high sensitivity of proton NMR lends itself 
to much shorter measuring times and smaller measuring volumes than required for 
equivalently localized phosphorous studies. Thus, more extensive spectroscopic pro- 
tocols that allow the determination of relaxation effects needed for any attempt to 
quantify spectroscopic findings may be recorded. 
An important aspect of in vivo NMR studies is a reliable spatial localization. In 
preceding papers (2-4) we have demonstrated that stimulated echo (STEAM) spec- 
troscopy provides a simple solution that is particularly suited to proton NMR. This 
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has been confirmed by preliminary applications of the technique to patients with 
brain tumors (5 ,6 )  and cerebral infarctions (7). No spectral contamination with reso- 
nances from normal brain tissue has been observed when the volume-of-interest 
(VOI) was fully localized inside the lesion. In this paper we report a more detailed 
study of cerebral metabolites that are currently accessible from localized proton 
NMR spectra of healthy volunteers. TI and T2 relaxation times as well as relative and 
absolute in vivo concentrations of metabolite resonances are determined in various 
regions of the brain and compared to the results of in vilro studies obtained using 
analytical techniques. 
METHODS 
The STEAM spectroscopy technique allows a reliable selection of a VOI as well as 
suppression of the unwanted water signal in a single experimental step. Its implemen- 
tation on a conventional whole-body MRI system (Siemens Magnetom) used here 
has been described in detail in a preceding paper (4).  The sequence comprises three 
slice selective RF pulses applied in the presence of magnetic field gradients according 
to 
9V( CHESS)-90"( # 1 )-TE/2-90"( #2)-TM-90"( #3)-TE/2-STE. [ 1 3  
Localization is accomplished by the fact that the acquired stimulated echo (STE) 
NMR signal originates only from spins that experience all three pulses. These spins 
are defined by the intersection of the three corresponding slices. Water suppression 
is achieved by preceding chemical-shift-selective (CHESS) pulses. Exciting only a nar- 
row frequency range (k0.4 ppm) around the water resonance (4.7 ppm), the resulting 
transverse magnetizations are spoiled. Thus, the slice-selective RF pulses of the 
STEAM sequence uniformly excite all other spectral ranges. This is an important 
advantage for quantitative evaluations. In the present study the middle interval TM 
was fixed to 30 ms, whereas the repetition time TR and the echo time TE were varied 
to obtain different TI and T2 weightings, respectively. A total of 14 healthy volunteers 
(male, 20-35 years) were investigated in five studies of the occipital area and the 
occipital lobe, and three studies of the insular area, the thalamus, and the cerebellum. 
Image selection as well as control of proper positions and dimensions of the VOI, 
either 3 X 3 X 3 or 4 X 4 X 4 cm3, was performed in all three orientations using an 
interleaved three-slice FLASH MRI sequence. 
RESULTS 
Figure 1 shows FLASH MR images and localized proton NMR spectra of the brain 
of a normal volunteer. The 4 X 4-cm2 squares in the axial and coronal images (Figs. 
1 a and 1 b) define a 64-ml VOI in the occipital area which has been selected for spec- 
troscopy of predominantly white matter. The series of water-suppressed proton spec- 
tra (Fig. lc) demonstrates the T2 dependence of individual metabolite resonances 
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FIG. 2. Sixty-four-megahertz (1.5-T) localized proton NMR spectra of predominantly white matter in 
the occipital area ofthe brain of a normal volunteer as indicated in Fig. 1 .  The series ofspectra at repetition 
times TR = 1500, 3000, and 6000 ms, respectively, demonstrates the T,  dependence of the individual 
metabolites (64 ml, TE = 50 ms, 128 scans). 
the series of spectra shown in Fig. 2 describes the TI dependence of metabolites in 
the same VOI using TR values of 1500,3000, and 6000 ms (TE = 50 ms, 128 scans). 
Resonance assignments ( I ,  4 )  are made to lactate (Lac, 1.3 ppm), acetate (Ac, 1.85 
ppm), N-acetylaspartate (NAA, 2.0 ppm), glutamate (Glu, 2.1 ppm), y-aminobuty- 
rate (GABA, 2.25 ppm), glutamine (Gln, 2.1 ppm, 2.45 ppm), aspartate (Asp, 2.8 
ppm), creatine and phosphocreatine (Cr/PCr, 3.0 ppm, 3.9 ppm), choline-containing 
compounds (Cho, 3.2 ppm), taurine (Tau, 3.3 ppm), and inositols (Ins, 3.5 ppm). 
Most spectral assignments (and relaxation times) have been confirmed by studies of 
model solutions using both the 1.5-T whole-body system with spatial localization and 
a conventional 7.0-T high-resolution NMR spectrometer. Further resonances with 
considerably lower intensities occur at 7.0-7.5 and 8.0-8.5 ppm and probably repre- 
sent exchangeable protons of cytosolic proteins and aromatic protons of adenine nu- 
cleotides, respectively. Residual lipid signals (0.5-1.5 ppm) may be due to contribu- 
tions from small regions containing fat as parts of the VOI extend beyond the right 
hemisphere (see Fig. 1 b). 
Similar images and spectra have been recorded from the insular area containing 
predominantly gray matter (Fig. 3), the cerebellum (Fig. 4), and the thalamus (Fig. 
5). For studies of the insular area and the thalamus the VOI was reduced to 27 ml(3 
X 3 X 3 cm3) to ensure better localization and to reduce partial volume effects. In the 
thalamus it turned out to be more difficult when compared to other areas to achieve 
a good field homogeneity by localized shimming on the VOI. The spectral quality 
shown in Fig. 5 is slightly degraded due to a 6-Hz linewidth compared to the usual 
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FIG. 3. Sixty-four-megahertz (1 S-T) FLASH MR images and localized proton NMR spectra of a normal 
volunteer from a 3 X 3 X 3 cm3 VOI in the insular area of the brain selected for in vivo spectroscopy of 
predominantly gray matter. (a) Axial image, (b) coronal image, and (c) series of spectra at echo times TE 
= 50, 135, and 270 ms, respectively, demonstrating the T2 dependence of the individual metabolites (27 
ml VOI, TR = 1500 ms, 5 12 scans). 
value of about 4 Hz. However, it is our impression that in vivo linewidths of 4-6 Hz 
are still determined by magnet inhomogeneities, shim current instabilities, and eddy 
current effects rather than due to natural T2 relaxation times or biological susceptibil- 
ity differences. T2 relaxation times of the order of 0.5 s translate into natural line- 
widths of less than 1 Hz. It should be noted that in this study no spectral processing 
was applied except a mild exponential multiplication of the data in the time domain. 
TI and T2 relaxation times of resonances from major metabolites in the investi- 
gated parts of the brain are summarized in Tables 1 and 2. The relaxation data were 
determined from both signal areas and peak intensities using a nonlinear Gauss- 
Newton fitting procedure for TI values and a linear least-squares fit for T2 values, 
respectively. Although T, and T2 calculations were based on only three repetition 
times or echo times and three to five independent volunteer studies, deviations of 
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FIG. 4. Sixty-four-megahertz (1.5-T) FLASH MR images and localized proton NMR spectra of a normal 
volunteer from a 4 X 4 X 4 cm3 VOI selected for in vivo spectroscopy of the cerebellum. (a) Sagittal 
image, (b) coronal image, and (c) series of spectra at echo times TE = 50, 135, and 270 ms, respectively, 
demonstrating the T2 dependence of the individual metabolites (64 ml VOI, TR = 1500 ms, 5 12 scans). 
individual experiments from the median values given in Tables 1 and 2 were always 
within a range of k-101. Particularly low variations were obtained for the creatine 
methyl resonance. Lactate relaxation times were obtained from patients with astrocy- 
tomas and cerebral infarctions exhibiting considerably enhanced concentrations of 
lactic acid (5- 7). Further relaxation times of metabolites with lower concentration 
and/or lower proton NMR signal strength such as aspartate, glutamine, glutamate, 
and GABA may be estimated from a qualitative comparison of spectra obtained at 
repetition times of 1500 and 6000 ms as well as at echo times of 50 and 270 ms, 
respectively. 
DISCUSSION 
Although it is not yet clear whether or not or to which extent the in vivo relaxation 
times and concentrations of cerebral metabolites are influenced by the brain function 
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FIG. 5.  Sixty-four-megahertz (1.5-T) FLASH MR images and localized proton NMR spectra of a normal 
volunteer from a 3 X 3 X 3 cm3 VOI selected for in vivo spectroscopy of the thalamus. (a) Sagittal image, 
(b) coronal image, and (c )  series of spectra at echo times TE = 50, 135, and 270 ms, respectively, demon- 
strating the T2 dependence of the individual metabolites (27 ml VOI, TR = I500 ms, 5 12 scans). 
only very small differences were observed between individuals of the rather homoge- 
neous group of volunteers studied here. In fact, the proton brain spectra turned out 
to be highly reproducible. The age dependence of the appearance of metabolites in 
proton brain spectra is the subject of a further investigation. On the other hand, a 
comparison of spectra recorded at the same echo time (Figs. lc, 3c, 4c, 5c) at first 
glance reveals regional differences in the normal human brain. However, since these 
effects may be due to either variations of metabolite concentrations or relaxation 
times or both, an interpretation of the spectra alone may be completely misleading. 
In particular, a change in the ratio of signal intensities gives only a rough indication of 
some change in either of the parameters, while no change may cover a compensatory 
behavior of relaxation times. and concentration. A proper elucidation and spectral 
interpretation requires the knowledge of T, and T2 relaxation times of individual 
metabolite resonances. 
Although TI and T2 values may be obtained in solution, it remains important to 
measure relaxation times in vivo in view of the large number of parameters involved 
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TABLE 1 
Spin-Lattice Relaxation Times TI of Major Metabolites Detected in Localized Proton 
NMR Spectra of the Normal Human Brain in Vivo 
Molecular d Insular Occipital 
Compound group (ppm) a m  area Thalamus Cerebellum 
Lac CH3 
Cr + PCr N-CH3 3.0 1750 1550 1750 1500 
N-CH2 3.9 1750 1050 - I 
Cho N-(CH3)3 3.2 1100 1150 I200 1500 
Tau N-CH2, S-CHI 3.3 - 1700 - - 
Ins CH(3-6) 3.5 1350 900 1100 1850 
1.3 - 1550 - - 
NAA CH3 2.0 1650 1450 1400 1700 
Note. Relaxation times are given in milliseconds. The data refer to median values with deviations of 
about +lo%. 
(pH, temperature, ions, proteins, cellular structures, etc.) and as a reference for alter- 
ations expected under pathological conditions. Possible complications may also arise 
from compartmentation and tissue heterogeneity. In fact, gradient-localized spectra 
may be further affected by T2 relaxation times that are modulated by exchange contri- 
butions, molecular diffusion, transport processes, or even macroscopic motion and 
flow (3). Quantitatively reliable evaluations are mainly expected for singlet resonance 
signals avoiding complications from differential J modulation effects on the STE sig- 
nal at different echo times. In fact, a TE value of 270 ms was selected to provide in- 
phase conditions for multiplets with spin-spin coupling constants J = 7 Hz such as 
observed for the lactate methyl group. 
TABLE 2 
Spin-Spin Relaxation Times T2 of Major Metabolites Detected in Localized Proton 
NMR Spectra of the Normal Human Brain in Vivo 
Molecular 6 Insular Occipital 
Compound group (ppm) area area Thalamus Cerebellum 
1.3 I 1200 - - Lac CH3 
NAA CH, 2.0 330 450 340 300 
Cr + PCr N-CH3 3.0 250 240 200 190 
N-CH2 3.9 160 190 - 120 
Cho N-(CH3)3 3.2 380 3 30 320 410 
Tau N-CHI, S-CHI 3.3 - 270 - - 
Ins CH(3-6) 3.5 130 110 150 130 
Note. Relaxation times are given in milliseconds. The data refer to median values with deviations of 
about +lo%. 
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TI Relaxation Times 
NMR relaxation times reflect mobility at the molecular level. Since the (proton) 
TI relaxation mechanism is mainly sensitive to local reorientational processes of an 
individual molecular group it is not surprising that the TI values of major metabolites 
reported in Table 1 are relatively close to each other without significant regional 
differences. The most reliable and accurate TI values of the singlet methyl resonances 
from NAA, Cr/PCr, and Cho were found to be within 1 100-1750 ms. Thus, repeti- 
tion times of the order of 1500 ms turn out to be well suited to optimizing the signal- 
to-noise per unit time in proton spectroscopy studies in vivo. 
In general, the high local mobility of a molecule or molecular group expressed by 
TI relaxation times of the order of 1000-2000 ms may be modulated by “solvent” 
properties. However, in this study TI values seem not to be correlated to the cytosolic 
viscosity affected by the mean protein concentrations of cellular water. In principle, 
a decrease in the protein concentration from gray and white matter to thalamus and 
cerebellum could facilitate molecular mobility and, therefore, prolong T, relaxa- 
tion times. 
T2 Relaxation Times 
It may be expected that a different molecular or cellular organization or utilization 
of a metabolite in various parts of the brain would preferentially result in different T2 
relaxation times sensing “slow” overall motions of whole molecules, bound mole- 
cules, or molecular aggregates. In fact, although differences in T2 relaxation times of 
cerebral metabolites were slightly more pronounced than differences in the TI values, 
no general trend may be deduced from the data in Table 2. The finding that the T2 
relaxation times of NAA in white matter regions, (450 & 50) ms in the occipital area 
and (500 & 50) ms in the occipital lobe, are much higher than the (320 & 30) ms 
found in other parts of the brain is in agreement with a recent report by others (8). It 
indicates particularly high mobility of NAA in white matter and may be related to its 
neuronal function. No significant regional variations were found for choline reso- 
nances with an average value of (360 k 40) ms and for creatine and phosphocreatine 
methyl resonances with a T2 of (220 k 20) ms. It is worth noting that the creatine 
relaxation behavior turned out to be perfectly monoexponential in contrast to what 
one may expect from a two-component resonance signal. Much smaller T2 values of 
about (1 30 -t 30) ms were found for the main inositol resonance probably originating 
from two to four of the six methine protons strongly coupled at 1.5 T. 
Another way of discussing mobility is to take the TI /T2 ratio as a measure of the 
degree of freedom for molecular reorientation. A ratio close to unity, i.e., T2 = T I ,  
is observed only for lactate, indicating free isotropic tumbling of the small molecule 
in the cytosol with correspondingly short correlation times. Only slight restrictions 
are observed for NAA and choline-containing compounds with T, /T2 ratios of about 
3-3.5. These values still refer to a high mobility of the N-acetyl groups of NAA and 
the trimethylammonium groups of free amounts of choline, phosphorylcholine, and 
glycerophosphorylcholine as well as of head groups of respective membrane constitu- 
ents. On the other hand, the somewhat surprising finding of a TI /T2 ratio of about 
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7.5 for the N-methyl resonance of Cr/PCr corresponds to a certain degree of immobi- 
lization. This may be due to a more bound state, e.g., within a molecular assembly, 
or to a localization in a cellular compartment of viscosity higher than that in the 
cytosol itself. Even higher T,/T2 ratios of about 8-14 are obtained for the inositol 
resonance. Since the NMR visible inositols are believed to be mainly due to phospha- 
tidy1 inositols, their more restricted mobility than that of choline residues is in quali- 
tative agreement with their difference in size and hydration. 
Concentrations of Cerebral Metabolites 
Table 3 summarizes relative in vivo concentrations of major cerebral metabolites 
in various parts of the brain as derived from localized proton NMR spectra. The 
numbers are normalized to 10 for total creatine in white matter. They were calculated 
by taking into account TI  and T, relaxation times (Tables 1 and 2), spectral peak 
areas at 50- and 270-ms echo times, the number of protons per molecular group, the 
size of the VOI, and the comparability of the coil sensitivity in applications to differ- 
ent volunteers. In fact, all spectra in this paper have been plotted in exactly the same 
way and are directly comparable except for photographic reproduction. 
In agreement with in vitro studies on horse and human brain using analytical tech- 
niques (9, lo), the relative concentration of NAA was found to be higher in gray 
and white matter than in the thalamus and the cerebellum. In fact, predominantly 
neuronal localization has been suggested for NAA, although its full role in cell metab- 
olism remains still unknown (I 1, 12). The concentration differences between gray 
and white matter are not as large as previously reported. This is mainly ascribed to 
significant partial volume effects in the selected positions in the occipital and insular 
area, respectively. Again in agreement with previous fluorometric studies of rat brain 
(13), the regional distribution of total creatine was found to be constant. Accordingly, 
the ratio of NAA/(Cr + PCr) for gray and white matter of about 1.65 is markedly 
higher than the value of 1.25 observed in the thalamus and cerebellum. 
Assuming a cerebral concentration of total creatine of about 10 mM(13-15), the 
TABLE 3 
Concentrations of Major Metabolites as Detected in Localized Proton NMR 
Spectra of the Normal Human Brain in Vivo 
Insular area Occipital area 
Compound Protons (gray matter) (white matter) Thalamus Cerebellum 
NAA 3 18 17 13 13 
Cr + PCr 3 11 - 10 11 10 
Cho 9 1.9 2.2 2.1 2.3 
Ins 2 8.8 6.0 7.4 7.4 
Note. Relative values are normalized to the concentration of total creatine in white matter. Assuming 
a cerebral concentration of total creatine of about 10 mM (13-13, the values may be read as absolute 
concentrations (in mM). 
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values given in Table 3 may be read as absolute concentrations. Thus, the most strik- 
ing observation is a 1 7- 1 8 mM NAA concentration in gray and white matter. These 
values are by a factor of 2-3 higher than the approximately 6 mM reported from a 
number of in vitro studies using biopsy material from different mammalian brains 
(10, 15-19). Since the NMR spectrum does not distinguish between N-acetyl moieties 
from NAA and other N-acetylated amino acids such as N-acetylglutamate and N- 
acetylaspartate glutamate, these may contribute to about 0.5 mM (20, 21). Even 
higher contributions of about 2 mM (22) may be due to N-acetyl moieties present in 
neuraminic acids found in the hydrophilic residues of glycoproteins, sialoproteins, 
and gangliosides. However, this is not believed to explain the considerable discrep- 
ancy of about 10 mM between the in vitro NAA determinations and the in vivo N- 
acetyl concentration. Since signal overlap with an eventually high glutamate reso- 
nance is also not very probable (see below), these findings need further experimental 
clarification. A promising approach may be studies of the time course of the NAA 
depletion recently observed in the early postischemic phase of stroke patients (7). 
Localized spectroscopy studies on animals may help to more directly investigate met- 
abolic alterations postmortem. 
A discussion of the concentration values obtained for inositol is complicated by 
the unknown number of protons contributing to its signal. In addition, the evaluation 
of T, relaxation times may be compromised by J modulation, and the signal may 
contain contributions from the glycine CH2 group which occurs at the same fre- 
quency as the single inositol peak originating from multiple collapsed resonances at 
1.5 T. In fact, a concentration of about 8 mM for phosphatidyl inositols (assuming 
two contributing protons) corresponds to analytical studies of human brain (23). The 
value is by a factor of 1.5 higher than that found in mouse brain (23) and by a factor 
of 1.7 lower than that reported for rabbit brain (15). The assumption of only two 
contributing inositol protons would double the concentration values given in Table 
3, Cytosolic concentrations of inositol phosphates have recently been reported to be 
less than 0.1 mM in rat brain (24) ,  and therefore are unable to explain the NMR 
observation. 
Further metabolite concentrations were estimated from their signal strength at cer- 
tain echo times. T,  and T2 relaxation times were either estimated from the in vivo 
results and/or measured in model solutions. Concentrations not included in Table 3 
refer to taurine and aspartate and are in agreement with biochemical expectations. 
While aspartate turned out to be about 1.5-2.5 mM, the concentration of 1.5-2.0 
mMfor taurine in the cerebellum was higher than that in the other parts of the brain. 
The surprisingly low signal intensities observed for glutamate and glutamine remain 
an open question even in view of the known complications from extensive line split- 
ting, multiplet overlap, and Jmodulation artifacts. In biopsied human cerebral cortex 
the concentrations of both amino acids were of the order of 6 M( 9). Similar consid- 
erations apply to the &CH2 group of aspartate in NAA. 
Finally, in a preceding paper ( 4 )  we have reported a concentration of 0.4 mM for 
cerebral lactate using the assumption of a 6.0 mMconcentration for NAA. This value 
has also been reported in a recent human in vivo NMR study by others (8). In a 
number of careful attempts to more accurately determine the cerebral lactate level in 
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vivo we observed a large variability of the signal strength between below detectability 
and a maximum value of about 1 .O mM in the occipital area or lobe. Although the 
lactate level (or other metabolite concentrations) may be affected by the physiological 
or functional status ofthe volunteers (e.g., eyes open or closed) no reproducible corre- 
lation could be established from the present studies due to actual signal-to-noise limi- 
tations. 
CONCLUSIONS 
Localized proton NMR spectroscopy has been demonstrated to resolve regional 
distribution patterns of metabolites in the normal human brain in vivo. Its high sensi- 
tivity and relatively short measuring times allow multiple spectroscopic recordings at 
different echo times and repetition times. NMR relaxation times T,  and T2 may indi- 
cate dynamical and structural differences in the cellular organization of certain me- 
tabolites in different parts of the brain. They also serve to noninvasively determine 
relative (and absolute) steady-state concentrations. 
On the basis of reliable spatial localization, acceptable investigational times of 1 - 
1.5 h, and access to a large number of compounds, the present experiments show the 
way to a wide range of hitherto impossible biochemical and physiological studies 
in vivo. For example, metabolic consequences of development and aging as well as 
biochemical effects of anesthetics, drugs, or alcohol (25) may now be monitored di- 
rectly in man. With the expected improvements in signal-to-noise and spectral resolu- 
tion even functional studies of the cerebral metabolism are within future possibilities. 
Medical applications of localized proton NMR spectroscopy will considerably im- 
prove the diagnostic specificity originally expected from MRI. There is hope to opti- 
mize therapeutic efficacy by directly monitoring biochemical response. Localized 
proton spectroscopy as a diagnostic tool for a noninvasive metabolic characterization 
of cerebral infarcts and tumors bears a great potential for replacing needle biopsy. 
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